Genentech

PULMOZYME - Cost

Last Updated: April 1st, 2024

HCPCS:

J7639

HCPCS Code Descriptor:

Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

Medicare Payment Limit:

The PULMOZYME Medicare Payment Limit is $52.034

Average Sale Price:

PULMOZYME ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The PULMOZYME Medicare Co-insurance percentage is 20%. PULMOZYME's Medicare Co-insurance amount is $10.41 per HCPCS unit.

APC Code:

The Pulmozyme APC Code is: not available

APC Payment Limit:

The APC Payment Limit for PULMOZYME is not available.

Pulmozyme Cost Information:

PULMOZYME, HCPCS J7693, became effective on January 1, 2009. Pricing remained constant between 2018 and 2022. Towards the end of 2022, prices began to trend upwards increasing by a few percentage points annually.

ACCESS PRICING AND MORE BY REGISTERING

Pulmozyme’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Pulmozyme’s average wholesale price (AWP) information was last updated on:
January 1, 2023